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Abstract:  
 The microbiota of an organism plays an essential role in maintaining the health of its 
host. Gut microbiota serve many functions such as aiding in host immunity and metabolism. 
When these communities are perturbed, they can deeply affect the livelihood of the host and 
increase their mortality. Agents such as antibiotics are prime examples of substances that can 
disrupt the gut microbial communities and weaken the hosts. This ultimately gives opportunistic 
pathogens the chance to overcome the natural flora. Honey bees are excellent models for 
studying the interactions between antibiotics and gut microbiota and can be used to further our 
understanding on these interactions in humans. In beekeeping and agriculture, the use of 
antibiotics is excessive. In beehives specifically, antibiotics such as tetracycline are used for 
larval protection against pathogens such as Serratia and Foulbrood. This prolonged exposure to 
antibiotics suggests the acquisition of antibiotic resistance genes in the microbiota of honey bees. 
Genomic analysis shows the presence of a family of tetracycline efflux pump genes in two core 
species, Gilliamella apicola and Snodgrassella alvi, in the honey bee gut. Further genomic 
analysis of Serratia isolated from local hives show the presence of MFS efflux pumps. Minimum 
Inhibitory Concentration assays performed on strains showing genetic markers for tetracycline 
resistance showed significant colony growth in the presence of antibiotics, even at the highest 
tested antibiotic concentrations. Further studies that determine precise inhibitory antibiotic 
concentrations, potential similarity between transpogenic elements and linkage between 
antibiotic resistance genes, and specific interactions between Serratia strains and core honey bee 
microbiota species can elucidate lingering questions regarding antibiotics and their effects on the 
microbiota.  
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Background:   
The microbiota of an organism is important to the organism’s health and quality of life. 
Functions of the microbiota in humans consist of nutrient metabolism, drug metabolism, and 
immunity against pathogens [Jandhyala et al., 2015]. Recent studies have shown that the 
microbiota can also influence the behavior and function of the central nervous system in an 
organism [Neufeld and Foster, 2009]. Studying the microbiota is essential in understanding the 
deeper connections microbes have in maintaining the health of different organisms.   
The gut microbial populations are highly sensitive and can be disturbed by several things: 
the most potent cause of these disturbances is antibiotics. Although antibiotics have been 
beneficial in numerous ways, these substances are known to impact the composition and size of 
the microbiota [Ng et al., 2013]. Studies have shown that dysbiotic microbiomes have impaired 
pathogen protection, nutrient metabolism, and vitamin production functions [Langdon et al., 
2016]. Upon treatment of antibiotics, the changes in the gut microbiota can be disturbed for 
weeks and sometimes cannot be restored to the original composition [Langdon et al., 2016]. The 
disturbed diversity of the microbiota makes host organisms more susceptible to opportunistic 
pathogens since the host no longer has the natural flora to defend against the pathogens 
[Langdon et al., 2016]. It is thus extremely important to study the effects antibiotics has on the 
gut flora of humans to help determine a better way of administrating antibiotics that does not 
further compromise the health of humans. Furthermore, studying how antibiotics perturbs the gut 
flora can help create more specific antibiotic treatment plans for sick individuals. Knowing more 
causative relations between microbiota, health, and antibiotic treatments can help evolve a 
method of treating bacterial infections more specifically such that it targets only harmful bacteria 
and not members of the original bacterial communities [Lemon et al, 2012].  
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Not only do antibiotics have negative effects on our microbiomes, but they also have 
negative effects on our ecosystem’s health. The growing use of antibiotics has led to a stark 
increase in the development of antibiotic resistant bacteria. The growing number of these 
antibiotic resistant bacteria pose a significant concern to the maintenance of a healthy gut 
microbiome. The development of antibiotic resistance in microbes comes about from either rare 
mutational events in bacterial genomes or from acquisition of resistant genes found in the 
environment [Cabello et al., 2006]. Acquiring these genes allows bacteria to respond differently 
in the presence of antibiotics, either structurally or metabolically [Witte, 1998].  
The sharp increase in antibiotic resistance in microbial communities stems from the over 
usage of antibiotics in agriculture, where antibiotic usage is often unregulated and administered 
in copious amounts. For example, studies in Denmark have showed that 24 grams of 
glycopeptide vancomycin were used in human therapy, whereas 24,000 kilograms of a similar 
glycopeptide avaparcin were used in animal feed to enhance and protect livestock [Witte,1998]. 
It is undeniable that human and animal microbes are connected, and the copious amounts of 
antibiotics given to animals will affect resistance levels in animals and subsequently humans as 
well.  
Honeybee populations across the country have had long exposure to antibiotics for 
combating bacterial diseases such as foulbrood that affects larvae of honeybees. Over the span of 
50 years, bee breeders across the United States have been using tetracycline to treat for these 
pathogens [Tian et al., 2012]. The prolonged exposure to these antibiotics had led to the increase 
of resistance in these communities, especially among pathogenic bacteria such as Paenibacillus 
larvae and Serratia marcescens which affect honeybee larvae [Climaco, 2017]. The combination 
of antibiotics causing dysbiosis in gut flora with the growing resistance of these pathogenic 
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bacteria have contributed to high mortality rates observed in honeybee populations [Raymann et 
al., 2017]. 
Honey bees, or Apis mellifera, are good model organisms that can be utilized to study the 
microbiota functions in humans. In humans, the microbiome fingerprint of each individual has 
complex interactions with the body that play a part in maintaining health. So far these results are 
purely correlative as there is not sufficient information to suggest causative relations between 
changes in microbiota and health. Honey bees are prime organisms in studying these interactions 
as they too have unique microbiome fingerprints similar to humans. Furthermore, bees acquire 
their microbiota through communal contact rather than external sources as do humans [Powell et 
al., 2014]. Furthermore, honey bees have much simpler digestive systems and are thus easier to 
manipulate. As a result, it is easier to gather causative data between changes in microbiota and 
changes in physiology in the honey bee. Trends determined in the honey bee can be used to 
further our understanding of the human gut microbiota. 
This study specifically focusses on Gilliamella apicola and Snodgrassella alvi, two 
known symbionts found in the ileum of honeybees [Kwong et al., 2014]. Their shared location in 
the honeybee guts presents an ideal opportunity to exchange antibiotic resistance genes through 
horizontal gene transfer. In this study, genomes of 53 isolates G. apicola and 32 isolates of S. 
alvi were scanned for of the presence of 17 tetracycline resistance genes to determine the 
prevalence and distribution of resistance genes. These 17 genes originate from two families of 
tetracycline resistant genes: one family consists of genes that encode for tetracycline efflux 
pumps and the other consists of genes that encode for ribosomal protection proteins. Species of 
S. marcescens isolated from lab beehives were also investigated to determine which tetracycline 
genes were prevalent. Minimum inhibitory concentration tests were conducted on bacterial 
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strains with tetracycline resistance genes to determine the level of resistance. These studies could 
illuminate how antibiotics like tetracycline are affecting honeybee microbiomes and help further 
our understanding of antibiotic effects on gut bacteria in honeybees and by extension, humans.   
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Methods:   
Media for Bacteria 4 
 In this study, Gilliamella apicola, Snodgrassella alvi, and a variety of pathogenic 
Serratia isolates were studied. Different growth media were utilized for optimal growth to 
cultivate these bacteria from freezer stocks. G. apicola and S. alvi were grown on blood agar 
plates comprising of Heart Infusion Agar from Criterion. Following provided instructions, agar 
was made and sterilized in the autoclave. Once cooled to 33°C, sheep blood was added to the 
media in a 5% blood to agar ratio. G. apicola and S. alvi grown on these plates were incubated in 
a 35°C CO2 incubator. Serratia species were grown on LB agar plates. These plates comprised of 
NaCL from Fisher Scientific, Bacto Tryptone from Becton Dickinson and Co., Yeast Extract 
from Affymetrix, and agar from Amresco. Bacteria colonized on these plates were incubated in a 
35°C CO2 incubator. 
Minimum Inhibitory Concentration Plate experiment  
 Minimum Inhibitory Concentration experiments are used to identify the minimal 
concentrations of antibacterial compounds necessary to inhibit microbial growth. Using a stock 
tetracycline solution of 12.5 mg/ml, agar media with tetracycline concentrations of 4 µg/ml, 8 
µg/ml, 16 µg/ml, 32 µg/ml were made. Blood agar media was made for G. apicola and S. alvi 
tests with the same protocol described above. Tetracycline was added with the sheep blood to 
create a homogenous mixture. The same method was used to make LB media with tetracycline 
for the Serratia MIC assays. 
 Freezer stocks of 5 S. alvi species, 6 G. apicola species, and 4 Serratia species with 
known genetic markers for tetracycline resistance were plated on their ideal growth media in a 
35°C CO2 incubator for 48-72 hours. Following incubation, 3 to 5 medium sized colonies were 
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selected from plates and inoculated in 1 ml of 1X Phosphate-buffered saline buffer. Large 
inoculation loops were rotated in micro-centrifuge tubes to break down large colonies. Solutions 
were briefly vortexed for 5 seconds. Each of the bacterial solutions were serially diluted to a 10-4 
cell per milliliter concentration. Fifty microliters of the 10-4 solution were pipetted on the 
appropriate tetracycline media plates. Three millimeter sterile glass beads were used to equally 
distribute solution across the agar. The plates remained at room temperature to dry and were then 
incubated in a 35°C CO2 incubator. Serratia plates were incubated for 48 hours before colonies 
were counted and S. alvi and G. apicola plates were checked between 48-72 hours depending on 
bacterial growth.  
BLAST Database  
 BLAST+ software was used to create databases of G. apicola, S. alvi, and Serratia 
genomes [BLAST+, 2004]. Genomes of these bacteria were compiled from different research 
projects and concatted and formatted into individual databases. Seven tetracycline resistance 
gene sequences that encode for ribosomal protection proteins against the antibacterial were 
retrieved from different species in a phylogenetic study conducted by Aminov et al. [Aminov et 
al., 2001]. Ten tetracycline resistance gene sequences utilizing efflux channels to remove 
tetracycline were retrieved from a variety of species in a different phylogenetic study conducted 
by Aminov et al. [Aminov et al., 2002]. These individual genes were located and concatenated 
into a query database and were compared against the genomic databases of these three bacterial 
species from bee guts. Bacterial species, percent identity, percent difference, bit scores, and e-
values were documented for each match between tetracycline genes and bacterial genomes. Code 
utilized in the experiment is provided in Appendix A.  
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Results:  
This study focusses on two bacterial symbionts that reside in the ileum of the honey bee gut. 
Complete genomes of 53 Gilliamella apicola and 32 Snodgrassella alvi strains were assembled 
and concatenated in two separate BLAST databases. Of the tested G. apicola, 53% of the strains 
were isolated from different bumble bee hosts and 28% of the strains were cultivated from honey 
bee hosts. Of the tested S. alvi strains, 62.5% of strains were cultivated from bumble bee hosts 
and 31% of strains were cultivated from honey bee hosts.  
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Figure 1. Presence of Tetracycline resistance in bee gut symbionts (A.)Presence or absence 
of Tetracycline resistance genes in S. alvi and G. apicola in bee gut microbiota. Manual BLASTn 
databases were made to assay 17 Tetracycline genes against 53 G. apicola and 32 S. alvi 
genomes. Bar lengths indicate proportion of antibiotic resistance strains to nonresistant strains 
from both families of bacteria. (B.) Distribution of hosts of tested G. apicola strains that showed 
presence of antibiotic resistance. 
Bumble bee and honey bee species were cultivated from different locations around the 
United States and parts of the world to get a wide distribution of test subjects. Seventeen 
tetracycline resistant genes from two different families of genes were collected from studies done 
by Aminov et al. in 2001 and 2002. BLAST+ was used to create databases and assay for isolated 
tetracycline resistance genes.  
Of the tested genomes, 10 out of 53 of G. apicola strains, or 18.8%, had antibiotic 
resistance genes (Figure 1A). Out of the 10 strains with evidence of antibiotic resistance genes, 2 
strains had more than one antibiotic resistance genes present (Figure 2). Of the tested S. alvi 
strains, 6 out of the 32 strains, or 18.75%, of the strains had antibiotic resistance genes (Figure 
1A). All of the S. alvi strains with antibiotic resistance came from Apis mellifera species. Of the 
10 strains of G. apicola with tetracycline resistance, 5 of these strains came from different 
Bombus hosts and 5 came from different Apis hosts (Figure 1B).  
Two families of tetracycline resistance genes were tested in these experiments. One 
family, tetracycline genes A through J, are phylogenetically related genes that encode for efflux 
pumps on cell membranes that evacuate molecules of tetracycline from the cell. The other family 
of genes, tetracycline genes M through Z, are also phylogenetically related and are genes that 
encode for ribosomal protection proteins. In all of the strains of S. alvi and G. apicola all 
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antibiotic resistance genes encoded for efflux pumps (Figure 2). None of the Serratia, S. alvi, 
and G. apicola strains had tetracycline resistance genes that encoded ribosomal protection 
proteins (Figure 2).  
Figure 2. Distribution of Tetracycline resistance genes in resistant bee gut microbiota 
Occurrence of 4 tetracycline genes in resistance strains of G. apicola and S. alvi (13 other genes 
were screened but not found). Different colors indicate presence of a particular gene which 
white boxes indicate no matches. Detailed information regarding each of the isolated 
tetracycline genes is found in Appendix B. Figure adapted from Tian et al. 2012 paper. 
 After assaying two natural resident symbiotic bacteria in bee gut microbiota, known 
honey bee pathogens were tested for antibiotic resistance. Genomes of 4 Serratia strains were 
sequenced, and tested for the presence of 17 tetracycline resistance genes. Genome sequences of 
Serratia strains KZ2, SS1, KZ11, and KZ19 were acquired from Raymann et al. Genomes of the 
four Serratia strains were concatenated in a locally created BLAST database and assayed for the 
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presence of the 17 tetracycline resistance genes. The results show no indication of any of these 
genes being present in the Serratia strains. However, genomes of all four Serratia showed 
annotations for tetracycline resistance genes. Examination of these genes showed the presence of 
tetracycline resistance MFS efflux pumps that are predominately found in Gram positive bacteria 
[Sun et al., 2014]. This MFS efflux pump gene was found in all four of the tested Serratia 
strains. 
 
 
Table 1. Colony counts of Minimum Inhibitory Concentration Assays for G. apicola, S. alvi, 
and Serratia strains Colony growth of different antibiotic resistant and nonresistant bacteria 
strains of Serratia (A), G. apicola (B), and S. alvi (C) on media with varied concentrations of 
Tetracycline. Plates with confluent or dense growth were labeled as TMTC, or too many to 
count.    
A. KZ11 (MFS) KZ19 (MFS) SS1 (MFS)  KZ2 (MFS) 
4 µg/ml 294 13 29 4 
8 µg/ml 218 20 39 6 
16 µg/ml 151 6 28 5 
32 µg/ml 69 0 1 4 
B. WKB7 (no 
tet gene) 
WKB112 (no 
tet gene) 
P62G (tetB) WKB1 
(tetB)  
P83G 
(tetB and 
tetH) 
P54G 
(tetB)  
4 µg/ml 0 0 580 281 30 TMTC 
8 µg/ml 0 0 560 368 32 TMTC 
16 µg/ml 0 0 278 TMTC 28 TMTC 
32 µg/ml 0 0 46 13 5 92 
C. WKB273 (no 
tet gene) 
WKB2 (tetC)  339 (tetD) 332 (tetD) WKB9 
(tetC) 
4 µg/ml 0 529 75 TMTC 19 
8 µg/ml 0 457 40 27 17 
16 µg/ml 0 TMTC TMTC 23 14 
32 µg/ml 0 318 53 17 14 
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 Minimum Inhibitory Concentration Assays were conducted next to determine 
concentrations of tetracycline that inhibited growth of Serratia, G. apicola, and S. alvi. Four 
different concentrations of tetracycline were tested against 4 strains of Serratia, 6 strains of G. 
apicola, and 5 strains of S. alvi. All strains of S. alvi and G. apicola with and without antibiotic 
resistance genes selected for the study originated from different Apis hosts. Of the G. apicola 
strains tested in these assays, strains identified as WKB7 and WKB112 were tested as controls 
since they showed no evidence of tetracycline resistance genes in their genomes. Of the S. alvi 
strains tested, the strain identified as WKB273 did not have evidence of tetracycline resistance 
genes in its genomes and served as a control in this experiments. All of the tested strains in the 
MIC assays showed confluent growth on media with no tetracycline present. Thus, for the 
purposes of this experiment, colony counts in environments with no tetracycline was excluded.  
In the tested S. alvi strains, all strains showed growth on the 32 µg/ml plates, suggesting 
high resistance to tetracycline. For strains WKB2 and WKB9, the highest growth is observed on 
the lowest tetracycline concentrations and the lowest growth is observed on the highest 
tetracycline concentrations. Both strains showed substantial growth on the highest tetracycline 
concentrations suggesting that 32 µg/ml of tetracycline was not enough to completely subdue 
growth of both bacterial strains. WKB2 showed increased growth at 16 µg/ml tetracycline and 
then markedly less growth at a 32 µg/ml of tetracycline. It is unclear as to why there was an 
increase in growth at that concentration. However, growth patterns of WKB2 and WKB9 strains 
show that TetC gene is able to sustain growth for these bacteria at high concentrations of 
tetracycline (Figure 3). S. alvi strains 339 and 332 showed similar trends as the previous two 
bacteria, displaying high growth at low tetracycline concentrations and low growth in higher 
concentrations. Strain 339’s growth pattern showed an unexpected dip at 8 µg/ml of tetracycline, 
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peak at 16 µg/ml of tetracycline, then dip again at the highest tetracycline concentration. It is 
unclear as to why there was dense growth at 16 µg/ml of tetracycline and not at lower 
concentrations of tetracycline. In all, strains 339 and 332 growth patterns suggest that TetD is 
also able to sustain bacterial growth in the presence of high concentrations of tetracycline (Figure 
3).  
Of the six strains of G. apicola tested, 4 had tetracycline resistance genes. Strain P62G 
showed a predictable reduction of growth from the low concentrations of tetracycline to high 
concentrations. At 32 µg/ml of tetracycline there were still 46 colonies observed which indicates 
that this concentration was not high enough to eliminate bacterial growth completely (Table 1B). 
Further study can be done with higher concentrations of tetracycline to determine the 
concentration of antibiotic that eliminates growth. The growth pattern of WKB1 showed some 
anomalies, as number of colonies observed at 8 µg/ml and 16 µg/ml were higher than the lowest 
and highest concentrations of tetracycline. Strain P83G showed decreased growth as tetracycline 
concentrations increased. Strain P54G showed decreased bacterial growth between 16 µg/ml and 
32 µg/ml of tetracycline suggesting that slightly higher concentrations of tetracycline would be 
sufficient to inhibit growth of P54G.  
 Serratia strain KZ19 showed no growth at 32 µg/ml of tetracycline indicating that a 
concentration between 16 µg/ml and 32 µg/ml or 32 µg/ml of tetracycline was sufficient to 
inhibit growth (Table 1A). Further study can be done at small increments to determine the exact 
concentration at which growth is inhibited. Serratia strain SS1 showed high amounts of growth 
at lower tetracycline concentrations and at 32 µg/ml of tetracycline, only 1 colony was observed 
(Table 1A). It can be concluded that tetracycline concentrations slightly higher than 32 µg/ml 
would be sufficient to inhibit growth of strain SS1. Strain KZ2 showed relatively steady growth 
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between all concentrations of tetracycline tested (Table 1A). This indicates that growth is not 
greatly affected as tetracycline concentrations in the environment increases. Strain KZ11 showed 
significant growth in the tested tetracycline concentrations (Table 1A). There were still 69 
colonies observed at 32 µg/ml concentration of tetracycline suggesting that KZ11 colonies were 
still able to sustain growth at that concentration (Table 1A). Further study needs to be done in 
order to determine concentration that inhibits growth.  
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Discussion and Future Study:  
 Honey bee microbiota is comprised of a specific gut community whose interactions 
promote the health of the honey bees. Through the use of agents like antibiotics, these 
interactions can be weakened or lost and can subsequently impact host health. Understanding the 
interactions between the microbiota and antibiotics can aid in our understanding of these 
interactions in humans and other animals.  
 The prominent use of antibiotics in the agricultural industry allows for the proliferation of 
antibiotics in our natural environment. The introduction of antibiotics in the natural environment 
stems from the large increase in livestock in the agricultural industry. [Khachatouriansm, 1998] 
With the purpose of antibiotics promoting growth in livestock, the increased amount of livestock 
in the industry leads to this increased use of antibiotics. [Khachatouriansm, 1998] The livestock 
in agriculture use 100 to 1000 times more antibiotics that humans each year. [Feinmen, 1998] A 
longitudinal study in Wisconsin showed that the increase of 0.25 kg to 1 kg per ton of antibiotics 
such as oxytetracycline being administered to livestock correlated with increased antibiotic 
resistance in certain E. coli species. [Khachatourians, 1998] The sheer amount of antibiotics in 
the environment and its prolonged usage contributes to the increase of antibiotic resistance in 
microbial communities not only within livestock, but also in other organisms like honey bees. 
The strains of G. apicola and S. alvi tested in the study originated from hives that supposedly 
were not exposed to antibiotics; however, there is some evidence of antibiotic resistance within 
the microbiota. This shows that antibiotics present in the environment is enough for microbes in 
different communities to develop antibiotic resistance, even if they aren’t exposed directly.  
 Tetracycline is a broad spectrum antibiotic that has been used in bee hives for decades 
[Tian et al., 2012]. Due to its prolonged use in bee keeping, the possibility of microbes in bee 
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communities developing resistance to these antibiotics increases. Genomic analysis of isolated 
G. apicola and S. alvi from different honey bee and bumble bee species show that tetracycline 
resistance genes, specifically TetB, TetH, TetC, and TetD, were found. These genes share 
ancestry, and all encode for tetracycline efflux pumps. These results show that the prolonged 
exposure of antibiotics in honeybees has allowed for the development of antibiotic resistance. 
However, of the 85 microbial genomes tested, only 16 genomes showed genetic markers of 
antibiotic resistance. This suggests that antibiotic resistance is present in these communities but 
at very low levels. Furthermore, the combination of results from the genetic analyses and MIC 
assays show that the presence of tetracycline resistance genes in the genomes are good indicators 
of the ability for these bacteria to withstand the effects of tetracycline. This shows that the ability 
to tolerate tetracycline is derived from the presence of the assayed genes and not from some 
unknown resistance genes with unrecognizable genetic sequences.  
The consequences of antibiotic treatments can be seen in their effects on natural gut flora. 
A study by Raymann et al. show that antibiotic treatment affects the microbial makeup of the 
honey bee gut, making the gut more susceptible to opportunistic pathogens like Serratia or 
American Foulbroud [Raymann et al., 2017]. These findings are substantiated by genomic 
analysis of G. apicola and S. alvi strains in this study. Due to their low level of observed 
resistance, it is expected that when treated with tetracycline, many of the bacterial strains will not 
be able to sustain growth. Moreover, the Raymann et al. study showed that the relative 
abundance of G. apicola increased a few days post treatment of tetracycline [Raymann et al., 
2017]. The high abundance of tetracycline resistance genes in G. apicola provides an explanation 
as to why this core gut species was able to withstand and grow under the presence of antibiotics. 
Colony counts from the MIC experiments further show that G. apicola strains with antibiotic 
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resistance genes are able to demonstrate significant growth in the presence of antibiotics. One 
particular G. apicola strain, P83G, from an Apis mellifera host had both Tet H and Tet B 
resistance genes in its genome. If this strain is found in many hosts, it might enhance host 
survival when exposed to antibiotics.  Further study could determine if the G. apicola strains that 
showed increased abundance in the Raymann et al. study had these genes in their genomes. Since 
strains of G. apicola with resistance genes can withstand high concentrations of tetracycline, as 
MIC assay results show, it is possible that these resistant G. apicola strains can be fed to honey 
bees to allow for G. apicola recolonization post treatment of tetracycline. Further study can be 
done to see if this would be enough to restore G. apicola populations in the gut microbiota and 
combat the emergence of pathogenic bacteria.  
G. apicola and S. alvi are both Gram negative bacteria that inhabit the ileum of the honey 
bee gut [Kwong et al., 2014]. These two bacteria have been shown to coevolve in the honey bee 
gut and can interchange genes through horizontal gene transfer [Kwong et al., 2014]. It was 
expected that because of these interactions there would be a high similarity in the genes found in 
both bacteria. The differences in observed genes suggest that these four genes were acquired 
independently or from other microbes found in the honey bee. Studies have shown that core 
species of the honey bee gut can carry antibiotic resistance and these results corroborate these 
findings [Raymann et al., 2017]. TetC, TetD, TetB, and TetH are all from the same family of 
genes and have similar mechanisms of protecting microbes against antibiotics. The similar 
family type of gene found between both species indicates a symbiotic relationship between both 
bacterial species. This indicates a coevolution between the two species which provides an 
explanation for the development of similar methods to combat exposure to antibiotics. Further 
study can be done to determine more closely the mechanisms behind the development of 
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antibiotic resistance genes in these microbes. Co-culturing studies can be done to show if direct 
transfers of these genes between these two symbionts is possible since the genomes of G. apicola 
and S. alvi assayed show no gene similarities. This would further verify that these bacteria can 
transfer genes amongst themselves in order to enhance gut microbial growth. Furthermore, 
transpogenic elements allowing these genes to transfer from microbe to microbe can be tested to 
determine if there is a link between specific transposons and genes. Although tetracycline 
resistance is primarily focused on in bee populations since tetracycline is a common treatment 
agent in bee hives, there is a possibility of linked coresistances developing following exposure to 
single antibiotics. [Levy and Marshal, 2013]. Genomic analysis for the presence of ampicillin 
resistance genes can also be done to determine whether there is any linkage between tetracycline 
and ampicillin resistant genes found in these gut microbes.  Since antibiotics have the potential 
of significantly perturbing gut microbiota, determining genetic linkages between transmitted 
genes can give better insight as to how antibiotic usage effects gut microbes on a genetic level.   
   Genetic analysis in this study found that Serratia strains isolated from different Apis 
mellifera hosts had genes for major facilitator superfamily (MFS) pumps [Kumar et al., 2013]. 
Serratia are opportunistic pathogens that are present in perturbed microbial communities of the 
honey bee gut [Moran et al., 2012]. The presence of Serratia and exposure to tetracycline have 
showed higher mortality in bees suggesting that Serratia can thrive on the dysbiosis in the 
microbiota caused by the antibiotics [Raymann et al., 2017]. This is supported by the findings of 
these MFS efflux genes found in Serratia that allow these strains to survive exposure to 
antibiotics. Minimum inhibitory concentration experiments show that most of the Serratia are 
able to maintain growth in high tetracycline concentrations such as 32 µl/mg. The ability for 
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Serratia to withstand these high concentrations would allow it to take advantage of the dysbiosis 
from antibiotic treatment.  
 Maintaining a healthy composition of microbes in the gut flora contributes greatly to the 
overall health of the organism and can aid in nutrition, immunity, and metabolism in hosts 
[Johnson et al., 2016]. Disturbance, whether an abundance in species or lack of, in these 
communities can lead to deficiencies in these functions and can ultimately result in death of the 
host. The presence of certain antibiotic resistance genes in G. apicola could explain the increased 
persistence in the gut with the introduction of tetracycline. When tested to see if growth is 
sustained at 32 µl/mg of tetracycline, high colony counts were observed for G. apicola and S. 
alvi strains with antibiotic resistance. What is interesting is that the G. apicola strain P83G had 
two antibiotic resistance genes detected in the genome; however, its ability to grow at high 
tetracycline concentrations was markedly less than other G. apicola strains that had one detected 
gene. Less growth could have been a result of both of the genes not being activated. Further 
studies should be done to determine whether both genes were expressed or whether certain 
circumstances activate expression of one gene over the other.  
 Results from this study give some more insight into the realm of antibiotic resistance but 
there is further study that can be conducted. Further genomic study can be done with the 
tetracycline gene markers present in the genomes. Since G. apicola and S. alvi are symbionts in 
the ileum, horizontal gene transfer can be a method of exchanging genes. Determining a link can 
further illuminate the why G. apicola and S. alvi strains did not share the same genes.  Further 
study can also be done between these symbionts and Serratia strains in bees. In this study it was 
observed that G. apicola and S. alvi strains were able to sustain much more growth than Serratia 
at similar tetracycline concentration. This implies that if these microbes grow in the same 
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environment, these core gut microbes could potentially overgrow the Serratia. Live bee 
experiments and microbiology experiments can be done to further investigate how tetracycline 
resistance strains of Serratia, G. apicola, and S. alvi strains interact to determine what 
specifically makes bees so susceptible to these pathogens after treatment of antibiotics despite 
growth of core species in the natural flora.  
 Overall, findings from this study attempt to address lingering questions about antibiotic 
resistance in honey bee gut microbes and pathogenic Serratia. Further studies and applications of 
these findings can be used to deepen our understanding of the relationship between gut 
microbiota and organism health.    
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Appendix A: Sample code for BLAST database built 
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Appendix B: Details on tetracycline resistance genes  
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Appendix C: Host and strain information for tested G. apicola genomes 
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Appendix D: Host and strain information for tested S. alvi genomes 
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